MedTrace Logo

Clinical Study to Evaluate the Efficacy of the Dietary Supplement UROMANNOSA® in Women With Recurrent Lower Urinary Tract Infections

NCT04880343 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2023-09-29

No results posted yet for this study

Summary

To analyze the clinical impact of a food supplement composed of D Mannose, cranberry extract (Cran-max) and Vitamin D3 in the prevention of recurrent lower urinary tract infections (UTI)

Conditions

  • Lower Urinary Tract Infection

Interventions

DIETARY_SUPPLEMENT

Group (A)

Group that will take a daily dose of the commercial dietary supplement provided by the sponsor, composed of mannose, cran-max and vitamin D for 6 months

DIETARY_SUPPLEMENT

Group (B)

Group that will take a daily dose of the commercial dietary supplement provided by the sponsor, composed of mannose, cran-max and vitamin D for 3 months

Sponsors & Collaborators

  • Carmen Gonzalez Enguita

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-26
Primary Completion
2024-01-26
Completion
2024-01-26

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04880343 on ClinicalTrials.gov